FTSE 100 rises on commodity stocks, jobs data boost; Oxford Biomedica jumps

London's FTSE 100 climbed on Tuesday, on gains in heavyweight mining and energy stocks, while better-than-expected jobs data strengthened views of a stronger economic recovery from a pandemic-driven crash last year. The blue-chip index rose 0.5%, with precious and base metal miners adding more than 1% each, as they benefited from higher metal and gold prices.

Reuters

Updated: 18-05-2021 13:53 IST | Created: 18-05-2021 13:53 IST

London's FTSE 100 climbed on Tuesday, on gains in heavyweight mining and energy stocks, while better-than-expected jobs data strengthened views of a stronger economic recovery from a pandemic-driven crash last year.

The blue-chip index rose 0.5%, with precious and base metal miners adding more than 1% each, as they benefited from higher metal and gold prices. Oil majors BP and Royal Dutch Shell, and banking stocks also rose, providing the biggest boost to the index.

The domestically focussed mid-cap FTSE 250 index climbed 0.7%. Britain's unemployment rate fell again, to 4.8% between January and March, and hiring rose further in April, according to data that showed employers gearing up for the easing of curbs.

"It is a general return to a bit of risk-on in the markets out there. We have some data out of the UK and several countries in Europe easing their restrictions have contributed to a general sense that the reopening is underway and that will boost cyclical stocks in particular," said Simona Gambarini, a markets economist at Capital Economics. The FTSE 100 has gained nearly 9.4% year-to-date as investors flocked to energy, materials and banking stocks that are seen benefiting the most from a stronger economic recovery due to speedy COVID-19 vaccinations and government support.

Fund managers loaded up on UK stocks and cut exposure to technology stocks as rising inflation and "taper tantrum" fears leave growth stocks vulnerable to pullbacks, Bank of America's May fund manager survey released on Tuesday found. Among other stocks, Oxford Biomedica gained 6% after it doubled the revenue expectation from its COVID-19 vaccine supply deal with drugmaker AstraZeneca.

Imperial Brands rose 2.1% after the tobacco company reiterated its full-year outlook. Mobile operator Vodafone Group slipped 6.9% on reporting a 1.2% drop in annual adjusted earnings, as COVID-19 hit roaming revenue and handset sales.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)

READ MORE ON

Capital EconomicsAstraZenecaBritainSimonaEuropeLondonRoyal Dutch ShellBank of America'sFTSE

READ MORE

OPINION / BLOG

LATEST NEWS

VIDEOS

View All